Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.81B |
| 2 |
Microsoft
MSFT
|
+$1.34B |
| 3 |
Apple
AAPL
|
+$1.25B |
| 4 |
Amazon
AMZN
|
+$1.17B |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$480M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPLK
Splunk Inc
SPLK
|
+$373M |
| 2 |
Amgen
AMGN
|
+$204M |
| 3 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
+$180M |
| 4 |
IMGN
Immunogen Inc
IMGN
|
+$160M |
| 5 |
SRC
SPIRIT REALTY CAPITAL, INC.
SRC
|
+$109M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.47% |
| 2 | Financials | 12.91% |
| 3 | Healthcare | 12.22% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Industrials | 9.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AVNS
1926
DELISTED
Avanos Medical
AVNS
| $20.2M | ﹤0.01% |
1,012,198
+21,413
| +2% | +$414K |
|
1927
1st Source
SRCE
$2.12B
| $20.2M | ﹤0.01% |
384,352
+15,724
| +4% | +$806K |
|
|
HIBB
1928
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $20.1M | ﹤0.01% |
261,712
-6,343
| -2% | -$455K |
|
1929
REX American Resources
REX
$1.41B
| $20.1M | ﹤0.01% |
683,640
+23,342
| +4% | +$514K |
|
1930
Regenxbio
RGNX
$708M
| $20M | ﹤0.01% |
950,551
+20,879
| +2% | +$372K |
|
1931
Deluxe
DLX
$1.15B
| $20M | ﹤0.01% |
972,259
+28,024
| +3% | +$557K |
|
|
BRKL
1932
DELISTED
Brookline Bancorp
BRKL
| $19.9M | ﹤0.01% |
2,000,462
+57,384
| +3% | +$580K |
|
1933
Metallus
MTUS
$898M
| $19.8M | ﹤0.01% |
890,423
+13,343
| +2% | +$278K |
|
1934
Repay Holdings
RPAY
$327M
| $19.8M | ﹤0.01% |
1,798,479
+46,603
| +3% | +$412K |
|
1935
Energy Recovery
ERII
$443M
| $19.8M | ﹤0.01% |
1,253,115
+37,064
| +3% | +$590K |
|
1936
PC Connection
CNXN
$2.12B
| $19.8M | ﹤0.01% |
300,074
+9,107
| +3% | +$597K |
|
1937
Vir Biotechnology
VIR
$1.49B
| $19.7M | ﹤0.01% |
1,949,189
+62,793
| +3% | +$640K |
|
1938
Kaspi.kz JSC
KSPI
$17.2B
| $19.7M | ﹤0.01% |
+153,500
| New | +$15.7M |
|
1939
Origin Bancorp
OBK
$1.66B
| $19.7M | ﹤0.01% |
631,868
+12,297
| +2% | +$381K |
|
|
DCPH
1940
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $19.7M | ﹤0.01% |
1,254,317
+33,009
| +3% | +$508K |
|
1941
TechTarget
TTGT
$278M
| $19.7M | ﹤0.01% |
594,689
+23,941
| +4% | +$788K |
|
|
AGNT
1942
AGNT Inc
AGNT
$734M
| $19.6M | ﹤0.01% |
1,899,569
+45,176
| +2% | +$554K |
|
1943
N-able
NABL
$940M
| $19.6M | ﹤0.01% |
1,499,325
+33,590
| +2% | +$444K |
|
|
PGRE
1944
DELISTED
Paramount Group
PGRE
| $19.6M | ﹤0.01% |
4,177,797
+75,078
| +2% | +$354K |
|
1945
Arcutis Biotherapeutics
ARQT
$3.18B
| $19.5M | ﹤0.01% |
1,971,433
+227,844
| +13% | +$1.7M |
|
1946
B&G Foods
BGS
$286M
| $19.5M | ﹤0.01% |
1,707,800
+118,696
| +7% | +$1.24M |
|
1947
Vicor
VICR
$10.2B
| $19.5M | ﹤0.01% |
509,398
+12,272
| +2% | +$477K |
|
1948
Sabre
SABR
$835M
| $19.5M | ﹤0.01% |
8,038,151
+156,151
| +2% | +$524K |
|
1949
Shenandoah Telecom
SHEN
$746M
| $19.4M | ﹤0.01% |
1,117,217
+24,910
| +2% | +$483K |
|
|
BASE
1950
DELISTED
Couchbase
BASE
| $19.4M | ﹤0.01% |
737,550
+30,065
| +4% | +$782K |
|
Similar funds
Geode Capital Management's Q1 2024 Portfolio in Review
As of Q1 2024, Geode Capital Management held 4,738 positions worth $1.08T, up 13% from $956B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Geode Capital Management deployed $32.6B of net new capital in Q1 2024, opening 85 new positions and adding to 3,720 existing holdings. Its largest new stake was Solventum: 2,733,775 shares worth $0.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Amgen, an estimated $204M trimmed.
- Geode Capital Management's largest Q1 2024 buy was Solventum: 2,733,775 shares worth $0.
- Geode Capital Management added most to NVIDIA in Q1 2024, an estimated $1.81B increase.
- Geode Capital Management's biggest Q1 2024 reduction was Amgen, cutting an estimated $204M.
- Geode Capital Management fully exited Splunk Inc in Q1 2024, selling an estimated $373M.
- Geode Capital Management's ten largest holdings make up 28% of its $1.08T portfolio in Q1 2024.
- Geode Capital Management opened 85 new positions and closed 123 in Q1 2024.
- Geode Capital Management's portfolio value rose 13% quarter-over-quarter to $1.08T.
Based on Geode Capital Management's 13F filing for Q1 2024, filed 13 May 2024.